Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Asthma
•
Primary Care
What is your preferred biologic for an asthmatic patient with a T2 low phenotype and who is a smoker?
Related Questions
Which patient characteristics or scenarios drive you to choose tezepelumab over dupilumab for asthma?
Should in-office oscillometry for lung function measurements be utilized in pediatric patients who are unable to reliably perform spirometry?
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
Do you use AIT as an adjunct therapy in addition to nasal sprays and oral medications for CRS?
When do you consider extending the dosing interval for patients on biologics with CRSwNP?
Should IVIG dosing in patients with autoimmune disease (i.e., dermatomyositis) who become pregnant continue to be based on actual weight at the time of each infusion, or should it be limited to pre-pregnancy weight?
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
How do you counsel parents about the anticipated abdominal pain associated with oral desensitization in peanut-allergic children?
What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?
How do you manage recurrent epistaxis from nasal steroids?
